Organic cation transporters in psychiatric and substance use disorders

Lauren E. Honan, Rheaclare Fraser-Spears, Lynette C. Daws

Producción científica: Review articlerevisión exhaustiva

1 Cita (Scopus)


Psychiatric and substance use disorders inflict major public health burdens worldwide. Their widespread burden is compounded by a dearth of effective treatments, underscoring a dire need to uncover novel therapeutic targets. In this review, we summarize the literature implicating organic cation transporters (OCTs), including three subtypes of OCTs (OCT1, OCT2, and OCT3) and the plasma membrane monoamine transporter (PMAT), in the neurobiology of psychiatric and substance use disorders with an emphasis on mood and anxiety disorders, alcohol use disorder, and psychostimulant use disorder. OCTs transport monoamines with a low affinity but high capacity, situating them to play a central role in regulating monoamine homeostasis. Preclinical evidence discussed here suggests that OCTs may serve as promising targets for treatment of psychiatric and substance use disorders and encourage future research into their therapeutic potential.

Idioma originalEnglish (US)
Número de artículo108574
PublicaciónPharmacology and Therapeutics
EstadoPublished - ene 2024

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Profundice en los temas de investigación de 'Organic cation transporters in psychiatric and substance use disorders'. En conjunto forman una huella única.

Citar esto